Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2010

View Archived Issues

Clinical data presented on rituximab in ANCA-associated vasculitis and SLE

Agennix discloses interim data from first-in-human trial of RGB-286638 in hematologic tumors

Chugai Pharma presents in vivo data on new potential cancer therapeutics

Thioketal nanoparticles deliver siRNA against TNF-alpha to inflamed intestines in colitis model

Elorac's naloxone lotion receives FDA orphan drug status in CTCL-associated pruritus

Neuraltus reports topline phase I data on NP-001 in ALS

Enrollment complete in phase III edoxaban trial for stroke prevention in AF

Hana Biosciences becomes Talon Therapeutics

Phase IIb trial of PT-003 in COPD meets primary efficacy endpoint

AstraZeneca identifies novel dipeptidyl peptidase 1 inhibitors

Spanish scientists patent new bivalent pyrazole derivatives

Novartis claims new inhibitors of sodium/glucose cotransporters

CardioVascular BioTherapeutics licenses phase II data for FGF-1

FDA approves Octaplex IND and grants fast track status

Scientists use [18F]-FDG PET-CT scan for early detection of cancer in subjects with LFS

GenSpera adds trial site to G-202 phase I clinical program

AMT and Amgen amend licencing agreement for GDNF gene therapies

Tolerx and the Cancer Research Institute partner for TRX-518

FDA provides complete response letter to GSK and Valeant for ezogabine

Shire reports efficacy and safety results from FAST-3 study of icatibant

Ascenta Therapeutics and Ascentage Pharma form alliance for cancer programs

Argos doses patients in phase IIb Arcelis personalized HIV immunotherapy trial

Michael J. Fox Foundation awards Allon grant for Parkinson's disease research

Gradient Echo Plural Contrast Imaging monitors progression of MS

TAvi6, a bispecific antibody targeting VEGF-A/ANG-2 inhibits angiogenesis in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...